APA (7th ed.) Citation

Shen, X., Yan, W., Zhang, E., Zhang, Z., Zhang, Z., & Dong, H. (2025). Adjuvant PD-1 inhibitors improve recurrence and survival outcomes in high-risk hepatocellular carcinoma patients after curative hepatectomy. European Journal of Medical Research, 30(1), 1. https://doi.org/10.1186/s40001-025-02444-3

Chicago Style (17th ed.) Citation

Shen, Xuehan, Wei Yan, Erlei Zhang, Zhiwei Zhang, Zunyi Zhang, and Hanhua Dong. "Adjuvant PD-1 Inhibitors Improve Recurrence and Survival Outcomes in High-risk Hepatocellular Carcinoma Patients After Curative Hepatectomy." European Journal of Medical Research 30, no. 1 (2025): 1. https://doi.org/10.1186/s40001-025-02444-3.

MLA (9th ed.) Citation

Shen, Xuehan, et al. "Adjuvant PD-1 Inhibitors Improve Recurrence and Survival Outcomes in High-risk Hepatocellular Carcinoma Patients After Curative Hepatectomy." European Journal of Medical Research, vol. 30, no. 1, 2025, p. 1, https://doi.org/10.1186/s40001-025-02444-3.